{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:45:05Z","timestamp":1787499905461,"version":"build-2736575974"},"reference-count":50,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"\n Importance<\/jats:title>\n Adherence, both in research trials and in clinical practice, is crucial to the success of interventions. There is limited guidance on strategies to increase adherence and the measurement and reporting of adherence in trials of melanoma self-management practices.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n This scoping review aimed to describe (1) strategies to improve adherence to self-management practices in randomized clinical trials of people at high risk of melanoma and (2) measurement and reporting of adherence data in these trials.<\/jats:p>\n <\/jats:sec>\n \n Evidence Review<\/jats:title>\n Four databases, including MEDLINE, Embase, CENTRAL, and CINAHL, were searched from inception to July 2022. Eligible studies were randomized clinical trials of self-monitoring interventions for early detection of melanoma in people at increased risk due to personal history (eg, melanoma, transplant, dysplastic naevus syndrome), family history of melanoma, or as determined by a risk assessment tool or clinical judgment.<\/jats:p>\n <\/jats:sec>\n \n Findings<\/jats:title>\n From 939 records screened, 18 eligible randomized clinical trials were identified, ranging in size from 40 to 724 participants, using a range of adherence strategies but with sparse evidence on effectiveness of the strategies. Strategies were classified as trial design (n\u2009=\u200915); social and economic support (n\u2009=\u20095); intervention design (n\u2009=\u200918); intervention and condition support (n\u2009=\u200910); and participant support (n\u2009=\u200918). No strategies were reported for supporting underserved groups (eg, people who are socioeconomically disadvantaged, have low health literacy, non-English speakers, or older adults) to adhere to self-monitoring practices, and few trials targeted provider (referring to both clinicians and researchers) adherence (n\u2009=\u20095). Behavioral support tools included reminders (n\u2009=\u20098), priority-setting guidance (n\u2009=\u20095), and clinician feedback (n\u2009=\u20095). Measurement of adherence was usually by participant report of skin self-examination practice with some recent trials of digital interventions also directly measuring adherence to the intervention through website or application analytic data. Reporting of adherence data was limited, and fewer than half of all reports mentioned adherence in their discussion.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Using an adaptation of the World Health Organization framework for clinical adherence, this scoping review of randomized clinical trials identified key concepts as well as gaps in the way adherence is approached in design, conduct, and reporting of trials for skin self-examination and other self-management practices in people at high risk of melanoma. These findings may usefully guide future trials and clinical practice; evaluation of adherence strategies may be possible using a Study Within A Trial (SWAT) framework within host trials.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamadermatol.2022.6478","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T11:01:21Z","timestamp":1677668481000},"page":"432","source":"Crossref","is-referenced-by-count":11,"title":["Strategies to Improve Adherence to Skin Self-examination and Other Self-management Practices in People at High Risk of Melanoma"],"prefix":"10.1001","volume":"159","author":[{"given":"Deonna M.","family":"Ackermann","sequence":"first","affiliation":[{"name":"Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bracken","sequence":"additional","affiliation":[{"name":"National Health and Medical Research Council Clinical Trials Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Janda","sequence":"additional","affiliation":[{"name":"Centre for Health Services Research, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Turner","sequence":"additional","affiliation":[{"name":"Biostatistics Centre, University of Otago, Dunedin, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolyn K.","family":"Hersch","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Drabarek","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy J. L.","family":"Bell","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"drv220009r1","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/S0895-4356(01)00457-7","article-title":"Treatment adherence in chronic disease.","volume":"54","author":"Dunbar-Jacob","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"drv220009r3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1745-6215-13-84","article-title":"Nonadherence to treatment protocol in published randomised controlled trials: a review.","volume":"13","author":"Dodd","year":"2012","journal-title":"Trials"},{"key":"drv220009r4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"drv220009r5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cct.2004.11.015","article-title":"Enhancing adherence in clinical research.","volume":"26","author":"Robiner","year":"2005","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"drv220009r6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/0197-2456(87)90021-3","article-title":"Patient compliance and the conduct and interpretation of therapeutic trials.","volume":"8","author":"Haynes","year":"1987","journal-title":"Control Clin Trials"},{"issue":"10","key":"drv220009r7","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jclinepi.2014.06.008","article-title":"Adherence measurement and patient recruitment methods are poor in intervention trials to improve patient adherence.","volume":"67","author":"Jeffery","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"drv220009r8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/jnci\/88.1.17","article-title":"Screening for cutaneous melanoma by skin self-examination.","volume":"88","author":"Berwick","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"drv220009r9","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jclinepi.2013.07.015","article-title":"Criteria for monitoring tests were described: validity, responsiveness, detectability of long-term change, and practicality.","volume":"67","author":"Bell","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"drv220009r10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamadermatol.2018.0021","article-title":"Patient preferences for follow-up after recent excision of a localized melanoma.","volume":"154","author":"Lim","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"1","key":"drv220009r11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jamadermatol.2021.4704","article-title":"Assessing the potential for patient-led surveillance after treatment of localized melanoma (MEL-SELF): a pilot randomized clinical trial.","volume":"158","author":"Ackermann","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"1","key":"drv220009r12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13063-021-05231-7","article-title":"Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up: a protocol for the MEL-SELF randomised controlled trial.","volume":"22","author":"Ackermann","year":"2021","journal-title":"Trials"},{"issue":"7","key":"drv220009r15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation.","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"drv220009r17","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"drv220009r18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11764-014-0412-0","article-title":"Effects of web-based intervention on risk reduction behaviors in melanoma survivors.","volume":"9","author":"Bowen","year":"2015","journal-title":"J Cancer Surviv"},{"issue":"3","key":"drv220009r19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10552-018-1096-y","article-title":"Randomized trial of a web-based survivor intervention on melanoma prevention behaviors of first-degree relatives.","volume":"30","author":"Bowen","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"4","key":"drv220009r20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/(ISSN)1097-0142","article-title":"A randomized trial to improve early detection and prevention practices among siblings of melanoma patients.","volume":"107","author":"Geller","year":"2006","journal-title":"Cancer"},{"issue":"4","key":"drv220009r21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2105\/AJPH.2008.155705","article-title":"A randomized trial of tailored skin cancer prevention messages for adults: Project SCAPE.","volume":"100","author":"Glanz","year":"2010","journal-title":"Am J Public Health"},{"issue":"2","key":"drv220009r22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1158\/1055-9965.EPI-14-0926","article-title":"Effects of tailored risk communications for skin cancer prevention and detection: the PennSCAPE randomized trial.","volume":"24","author":"Glanz","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"drv220009r23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1037\/a0021387","article-title":"Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients.","volume":"29","author":"Manne","year":"2010","journal-title":"Health Psychol"},{"issue":"7","key":"drv220009r24","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/tbm\/ibaa103","article-title":"Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection among individuals diagnosed with melanoma.","volume":"11","author":"Manne","year":"2021","journal-title":"Transl Behav Med"},{"issue":"8","key":"drv220009r25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/abm\/kaab090","article-title":"mySmartCheck, a digital intervention to promote skin self-examination among individuals diagnosed with or at risk for melanoma: a randomized clinical trial.","volume":"56","author":"Manne","year":"2022","journal-title":"Ann Behav Med"},{"issue":"5","key":"drv220009r26","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s40257-018-0372-7","article-title":"Piloting the use of smartphones, reminders, and accountability partners to promote skin self-examinations in patients with total body photography: a randomized controlled trial.","volume":"19","author":"Marek","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"drv220009r27","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.amepre.2003.10.006","article-title":"Patient adherence to skin self-examination: effect of nurse intervention with photographs.","volume":"26","author":"Oliveria","year":"2004","journal-title":"Am J Prev Med"},{"issue":"1","key":"drv220009r28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/archderm.143.1.37","article-title":"Efficacy of a partner assistance intervention designed to increase skin self-examination performance.","volume":"143","author":"Robinson","year":"2007","journal-title":"Arch Dermatol"},{"issue":"1","key":"drv220009r29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/archdermatol.2009.350","article-title":"Comparing the efficacy of an in-person intervention with a skin self-examination workbook.","volume":"146","author":"Robinson","year":"2010","journal-title":"Arch Dermatol"},{"issue":"9","key":"drv220009r30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamadermatol.2016.1985","article-title":"Early detection of new melanomas by patients with melanoma and their partners using a structured skin self-examination skills training intervention: a randomized clinical trial.","volume":"152","author":"Robinson","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"19","key":"drv220009r31","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.1002\/cam4.v9.19","article-title":"Remote skin self-examination training of melanoma survivors and their skin check partners: a randomized trial and comparison with in-person training.","volume":"9","author":"Robinson","year":"2020","journal-title":"Cancer Med"},{"issue":"3","key":"drv220009r32","doi-asserted-by":"publisher","DOI":"10.2196\/37539","article-title":"The achieving self-directed integrated cancer aftercare intervention for detection of recurrent and second primary melanoma in survivors of melanoma: pilot randomized controlled trial.","volume":"8","author":"Murchie","year":"2022","journal-title":"JMIR Cancer"},{"issue":"2","key":"drv220009r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.0001","article-title":"Effect of a skin self-monitoring smartphone application on time to physician consultation among patients with possible melanoma: a phase 2 randomized clinical trial.","volume":"3","author":"Walter","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"drv220009r34","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/bjd.2015.172.issue-4","article-title":"A pilot trial of mobile, patient-performed teledermoscopy.","volume":"172","author":"Manahan","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6","key":"drv220009r35","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1188\/03.ONF.1029-1036","article-title":"Skin self-examination in patients at high risk for melanoma: a pilot study.","volume":"30","author":"Phelan","year":"2003","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"drv220009r36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/ajd.2009.50.issue-3","article-title":"Thoroughness of skin examination by melanoma patients: influence of age, sex and partner.","volume":"50","author":"Boone","year":"2009","journal-title":"Australas J Dermatol"},{"issue":"9","key":"drv220009r37","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1001\/jamadermatol.2015.0690","article-title":"Comparison of efficacy of differing partner-assisted skin examination interventions for melanoma patients: a randomized clinical trial.","volume":"151","author":"Turrisi","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"1","key":"drv220009r38","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.2883","article-title":"Skin self-examination education for early detection of melanoma: a randomized controlled trial of Internet, workbook, and in-person interventions.","volume":"16","author":"Robinson","year":"2014","journal-title":"J Med internet Res"},{"issue":"1","key":"drv220009r39","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1111\/ajd.2019.60.issue-1","article-title":"Remote partner assisted skin self-examination skills training of melanoma survivors and their partners.","volume":"60","author":"Robinson","year":"2019","journal-title":"Australas J Dermatol"},{"issue":"2","key":"drv220009r40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5430\/jnep.v4n2p253","article-title":"Enhanced fidelity of an educational intervention on skin self-examination through surveillance and standardization.","volume":"4","author":"Gaber","year":"2014","journal-title":"J Nurs Educ Pract"},{"key":"drv220009r41","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"8","key":"drv220009r42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-056755","article-title":"Describing, predicting and explaining adherence to total skin self-examination (TSSE) in people with melanoma: a 12-month longitudinal study.","volume":"12","author":"Allan","year":"2022","journal-title":"BMJ Open"},{"issue":"15","key":"drv220009r43","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJMe2114651","article-title":"Striving for diversity in research studies.","volume":"385","author":"Rubin","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"drv220009r44","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1186\/s13063-022-06553-w","article-title":"Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups-practical guidance to support better practice.","volume":"23","author":"Dawson","year":"2022","journal-title":"Trials"},{"issue":"6","key":"drv220009r45","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/bjd.2019.180.issue-6","article-title":"Effectiveness of interventions to support the early detection of skin cancer through skin self-examination: a systematic review and meta-analysis.","volume":"180","author":"Ersser","year":"2019","journal-title":"Br J Dermatol"},{"issue":"5","key":"drv220009r46","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.pec.2019.12.009","article-title":"Operationalization of skin self-examination in randomized controlled trials with individuals at increased risk for melanoma: a systematic review.","volume":"103","author":"Coroiu","year":"2020","journal-title":"Patient Educ Couns"},{"issue":"5","key":"drv220009r47","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/tbm\/ibaa003","article-title":"Prevalence and correlates of skin self-examination behaviors among melanoma survivors: a systematic review.","volume":"10","author":"Bhurosy","year":"2020","journal-title":"Transl Behav Med"},{"key":"drv220009r48","doi-asserted-by":"publisher","first-page":"h2147","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose.","volume":"350","author":"Loudon","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"drv220009r49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13063-018-2535-5","article-title":"Trial Forge Guidance 1: what is a Study Within A Trial (SWAT)?","volume":"19","author":"Treweek","year":"2018","journal-title":"Trials"},{"issue":"1","key":"drv220009r50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13063-019-3980-5","article-title":"Trial Forge Guidance 2: how to decide if a further Study Within A Trial (SWAT) is needed.","volume":"21","author":"Treweek","year":"2020","journal-title":"Trials"},{"key":"drv220009r2","volume-title":"Adherence to long-term therapies: evidence for action","author":"World Health Organization","year":"2003"},{"key":"drv220009r14","volume-title":"JBI Manual for Evidence Synthesis","author":"Peters","year":"2020"},{"key":"drv220009r13","unstructured":"Ackermann? D, Bracken? K, Hersch? J, . Strategies to improve participant recruitment, retention, response, and intervention adherence in randomised controlled trials of early detection in populations at high risk of melanoma: a scoping review protocol. OSF Registries. 2021. Accessed January 5, 2023. https:\/\/archive.org\/details\/osf-registrations-5f7mh-v1"},{"key":"drv220009r16","unstructured":"Northern Ireland Hub for Trials Methodology Research. SWAT repository store. Accessed February 14, 2021. https:\/\/www.qub.ac.uk\/sites\/TheNorthernIrelandNetworkforTrialsMethodologyResearch\/SWATSWARInformation\/Repositories\/SWATStore\/"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2801703\/jamadermatology_ackermann_2023_rv_220009_1681833172.53171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T11:14:20Z","timestamp":1681902860000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2801703"}},"subtitle":["A Scoping Review of Randomized Clinical Trials"],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2022.6478","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,1]]}}}